Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Gudin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pain and Therapy|November 23, 2016
Oxycodone DETERx<sup>®</sup>: A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients with Chronic PainJeff Gudin
Postgraduate Medicine|January 5, 2020
Utility of lidocaine as a topical analgesic and improvements in patch delivery systemsJeff Gudin, Sri Nalamachu
Pain Medicine (Malden, Mass.)|November 19, 2013
The downside of upschedulingJeff Gudin, Anna J Lee
Pain Physician|April 21, 2026
Comments on "Could the Hanging Drop Technique Be an Alternative Method to Loss of Resistance in Cervical Epidural Injections?"Jeff Gudin, Danielle Bodzin Horn
Pain Medicine (Malden, Mass.)|January 12, 2017
Response to Crudele et al. Commentary on Gudin et al. "Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties"Jeff Gudin, Ernest A Kopecky, Alison B Fleming
Pain Medicine (Malden, Mass.)|March 21, 2016
SoluMatrix® Diclofenac: Sustained Opioid-Sparing Effects in a Phase 3 Study in Patients with Postoperative PainCharles Argoff, Bill McCarberg, Jeff Gudin, et al.
Journal of Pain Research|August 14, 2025
Postmarketing Research for Opioid Abuse-Deterrent Formulations: A Narrative ReviewLynn Webster, Jeff Gudin, Jody L Green, et al.
Journal of Opioid Management|September 25, 2010
Acute opioid withdrawal precipitated by ingestion of crushed embeda (morphine extended release with sequestered naltrexone): case report and the focused review of the literatureXiulu Ruan, Tao Chen, Jeff Gudin, et al.
Pain Medicine (Malden, Mass.)|June 26, 2015
Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent PropertiesJeff Gudin, Naama Levy-Cooperman, Ernest A Kopecky, et al.
Journal of Opioid Management|November 23, 2020
Shorter drug testing intervals are associated with improved drug misuse ratesJeff Gudin, Neel Mehta, F Leland McClure, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pain and Therapy|November 23, 2016
Oxycodone DETERx<sup>®</sup>: A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients with Chronic PainJeff Gudin
Postgraduate Medicine|January 5, 2020
Utility of lidocaine as a topical analgesic and improvements in patch delivery systemsJeff Gudin, Sri Nalamachu
Pain Medicine (Malden, Mass.)|November 19, 2013
The downside of upschedulingJeff Gudin, Anna J Lee
Pain Physician|April 21, 2026
Comments on "Could the Hanging Drop Technique Be an Alternative Method to Loss of Resistance in Cervical Epidural Injections?"Jeff Gudin, Danielle Bodzin Horn
Pain Medicine (Malden, Mass.)|January 12, 2017
Response to Crudele et al. Commentary on Gudin et al. "Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties"Jeff Gudin, Ernest A Kopecky, Alison B Fleming
Pain Medicine (Malden, Mass.)|March 21, 2016
SoluMatrix® Diclofenac: Sustained Opioid-Sparing Effects in a Phase 3 Study in Patients with Postoperative PainCharles Argoff, Bill McCarberg, Jeff Gudin, et al.
Journal of Pain Research|August 14, 2025
Postmarketing Research for Opioid Abuse-Deterrent Formulations: A Narrative ReviewLynn Webster, Jeff Gudin, Jody L Green, et al.
Journal of Opioid Management|September 25, 2010
Acute opioid withdrawal precipitated by ingestion of crushed embeda (morphine extended release with sequestered naltrexone): case report and the focused review of the literatureXiulu Ruan, Tao Chen, Jeff Gudin, et al.
Pain Medicine (Malden, Mass.)|June 26, 2015
Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent PropertiesJeff Gudin, Naama Levy-Cooperman, Ernest A Kopecky, et al.
Journal of Opioid Management|November 23, 2020
Shorter drug testing intervals are associated with improved drug misuse ratesJeff Gudin, Neel Mehta, F Leland McClure, et al.
Pageof 2